DrugPatentWatch Database Preview
Profile for Australia Patent: 2006243859
US Patent Family Members and Approved Drugs for Australia Patent: 2006243859
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Apr 15, 2027 | Boehringer Ingelheim | SYNJARDY XR | empagliflozin; metformin hydrochloride |
➤ Sign Up | Apr 15, 2027 | Boehringer Ingelheim | GLYXAMBI | empagliflozin; linagliptin |
➤ Sign Up | Apr 15, 2027 | Boehringer Ingelheim | JARDIANCE | empagliflozin |
➤ Sign Up | Apr 15, 2027 | Boehringer Ingelheim | SYNJARDY | empagliflozin; metformin hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |